These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 11254383

  • 1. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL, Ruff M, Kannan R, Cuniasse P, Yiotakis A, Dive V, Rio MC, Basset P, Moras D.
    J Mol Biol; 2001 Mar 23; 307(2):577-86. PubMed ID: 11254383
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H, Werle K, Bauer MM, Dollinger H, Jung B.
    J Mol Biol; 2001 Sep 28; 312(4):743-51. PubMed ID: 11575929
    [Abstract] [Full Text] [Related]

  • 3. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K.
    J Mol Biol; 2001 Sep 28; 312(4):731-42. PubMed ID: 11575928
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 5. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M.
    J Med Chem; 1999 May 20; 42(10):1723-38. PubMed ID: 10346925
    [Abstract] [Full Text] [Related]

  • 6. Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
    Kannan R, Ruff M, Kochins JG, Manly SP, Stoll I, El Fahime M, Noël A, Foidart JM, Rio MC, Dive V, Basset P.
    Protein Expr Purif; 1999 Jun 20; 16(1):76-83. PubMed ID: 10336863
    [Abstract] [Full Text] [Related]

  • 7. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
    Amano T, Kwak O, Fu L, Marshak A, Shi YB.
    Cell Res; 2005 Mar 20; 15(3):150-9. PubMed ID: 15780176
    [Abstract] [Full Text] [Related]

  • 8. High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: insight into inhibitor binding.
    Lingott T, Schleberger C, Gutiérrez JM, Merfort I.
    Biochemistry; 2009 Jul 07; 48(26):6166-74. PubMed ID: 19485419
    [Abstract] [Full Text] [Related]

  • 9. Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
    Bertini I, Calderone V, Fragai M, Luchinat C, Mangani S, Terni B.
    J Mol Biol; 2004 Feb 20; 336(3):707-16. PubMed ID: 15095982
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
    Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W.
    Nature; 1997 Sep 04; 389(6646):77-81. PubMed ID: 9288970
    [Abstract] [Full Text] [Related]

  • 11. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
    Pavlovsky AG, Williams MG, Ye QZ, Ortwine DF, Purchase CF, White AD, Dhanaraj V, Roth BD, Johnson LL, Hupe D, Humblet C, Blundell TL.
    Protein Sci; 1999 Jul 04; 8(7):1455-62. PubMed ID: 10422833
    [Abstract] [Full Text] [Related]

  • 12. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
    Amano T, Fu L, Sahu S, Markey M, Shi YB.
    Int J Mol Med; 2004 Aug 04; 14(2):233-9. PubMed ID: 15254771
    [Abstract] [Full Text] [Related]

  • 13. Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
    Noël A, Boulay A, Kebers F, Kannan R, Hajitou A, Calberg-Bacq CM, Basset P, Rio MC, Foidart JM.
    Oncogene; 2000 Mar 16; 19(12):1605-12. PubMed ID: 10734321
    [Abstract] [Full Text] [Related]

  • 14. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
    Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F.
    J Med Chem; 2009 Feb 26; 52(4):1040-9. PubMed ID: 19173605
    [Abstract] [Full Text] [Related]

  • 15. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D, Moldoveanu T, Inoue J, Davies PL, Campbell RL.
    Biochemistry; 2006 Jun 20; 45(24):7446-52. PubMed ID: 16768440
    [Abstract] [Full Text] [Related]

  • 16. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
    Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD.
    Protein Sci; 1995 Oct 20; 4(10):1966-76. PubMed ID: 8535233
    [Abstract] [Full Text] [Related]

  • 17. Crystal structures of acutolysin A, a three-disulfide hemorrhagic zinc metalloproteinase from the snake venom of Agkistrodon acutus.
    Gong W, Zhu X, Liu S, Teng M, Niu L.
    J Mol Biol; 1998 Oct 30; 283(3):657-68. PubMed ID: 9784374
    [Abstract] [Full Text] [Related]

  • 18. Using model complexes to augment and advance metalloproteinase inhibitor design.
    Jacobsen FE, Cohen SM.
    Inorg Chem; 2004 May 17; 43(10):3038-47. PubMed ID: 15132609
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A, Koellner G, Wielgus-Kutrowska B, Stroh A, Raszewski G, Holý A, Steiner T, Frank J.
    J Mol Biol; 2004 Sep 17; 342(3):1015-32. PubMed ID: 15342253
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, Wendt KU.
    Chem Biol; 2005 Feb 17; 12(2):181-9. PubMed ID: 15734645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.